Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development | Psychedelic Invest
Revive Therapeutics Ltd. (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs